chitosan has been researched along with Glaucoma in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (2.78) | 29.6817 |
| 2010's | 23 (63.89) | 24.3611 |
| 2020's | 12 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelfattah, EA; El-Kamel, A; El-Moslemany, RM; Mehanna, RA; Radwan, SE; Thabet, EH | 1 |
| Di Luca, M; Ioannou, N; Lamprou, DA; Luo, J; Mathew, E; Qin, M; Tagalakis, AD; Yu-Wai-Man, C | 1 |
| Alemezadeh, SA; Bagherzadeh, K; Hosseini, MS; Mehravi, B; Mirzaei, M; Mohseni, M; Naseripour, M | 1 |
| Kumara, BN; Nirmal, J; Prasad, KS; Shambhu, R; Shim, YB | 1 |
| Cardoso, VN; Castilho, RO; Cronemberger, S; Faraco, AAG; Fernandes, SOA; Ferreira, AJ; Foureaux, G; Franca, JR; Fuscaldi, LL; Nogueira, JC; Ribeiro, TG; Yoshida, MI | 1 |
| Dangi, JS; Dubey, V; Kesavan, K; Mohan, P | 1 |
| Lai, JY; Luo, LJ; Nguyen, DD | 2 |
| Lai, JY; Lue, SJ; Luo, LJ; Nguyen, DD | 1 |
| Kumara, BN; Prasad, KS; Shambhu, R | 1 |
| Ji, Y; Liu, Y; Wu, X | 1 |
| Choy, YB; Ha, A; Kim, DW; Kim, SN; Kim, YJ; Kim, YK; Min, CH; Park, KH; Park, M | 1 |
| Han, Y; Lin, Q; Liu, S; Wang, Y; Zhao, X | 1 |
| Han, B; Jiang, Z; Liu, W; Peng, X; Qiao, J; Qiao, X; Yang, C | 1 |
| Chen, Y; Gui, R; Hou, D; Li, J; Ping, Q; Tao, Q; Tian, S; Yang, F; Zang, L; Zhao, Y | 1 |
| Chang, YF; Cheng, YH; Huang, SH; Ko, YC; Liu, CJ | 1 |
| Ahmad, Z; Al-Kinani, AA; Alany, RG; Arshad, MS; Chang, MW; Mehta, P; Singh, N; van der Merwe, SM | 1 |
| Barwal, I; Dada, T; Kumar, R; Yadav, SC | 1 |
| Dhyanandhan, G; Jain, K; Kumar, RS; Sood, S | 1 |
| Haniuda, H; Ito, K; Kashiwagi, K; Ohtsubo, S; Takeoka, S | 1 |
| Ali, A; Aqil, M; Chuttani, K; Katiyar, S; Mishra, AK; Mondal, RS; Pandit, J; Sultana, Y | 1 |
| Ali, A; Ali, J; Bhatnagar, A; Kumar, N | 1 |
| Chiou, SH; Hsiao, MH; Hung, KH; Larsson, M; Liu, CJ; Liu, DM; Wang, YL | 1 |
| Chen, M; Duan, L; Ge, J; Huang, L; Li, X; Ma, J; Quan, D; Xi, L; Zhang, W; Zhang, Z | 1 |
| Chen, L; Huang, Y; Jiang, S; Li, R; Shi, K; Wang, F; Xu, Q; Zhang, D | 1 |
| Cardoso, VN; Castilho, RO; Cronemberger, S; Faraco, AA; Fernandes, SO; Ferreira, AJ; Foureaux, G; Franca, JR; Fulgêncio, Gde O; Fuscaldi, LL; Nogueira, JC; Ribeiro, TG; Yoshida, MI | 1 |
| Chen, X; Guo, F; Li, H; Li, L; Tan, Y; Xie, L; Xu, D; Zhu, X | 1 |
| Cabral, LM; Costa, CM; de Sousa, VP; dos Santos, EP; Franca Presgrave, OA; Louvisse de Abreu, LC; Nicoli, S; Ricci Junior, E; Rocha Pierucci, AP; Rodrigues, CR | 1 |
| Cheng, YH; Chien, CS; Chiou, SH; Chiu, AW; Jhan, YY; Liu, CJ; Tsai, KL; Tsai, TH | 1 |
| Anirudhan, TS; Nair, AS; Parvathy, J | 1 |
| Lai, JY; Luo, LJ | 1 |
| Abd-Elgawad, AH; El-Dahan, MS; Jablonski, MM; Maria, DN; Soliman, OA | 1 |
| Paliwal, R; Paliwal, SR; Vyas, SP; Wadhwa, S | 1 |
| CAI, X; CHEN, RF; CHENG, LZ; FAN, JZ; GUO, H; LAN, YQ; YANG, LQ; ZHANG, LM; ZHOU, HS | 1 |
| Aburahma, MH; Mahmoud, AA | 1 |
| Almeida, JF; Baptista, CM; Fonseca, A; Gil, MH; Leite, E | 1 |
1 review(s) available for chitosan and Glaucoma
| Article | Year |
|---|---|
Why chitosan could be apt candidate for glaucoma drug delivery - An overview.
Topics: Administration, Ophthalmic; Biocompatible Materials; Chitosan; Contact Lenses; Corneal Injuries; Drug Carriers; Drug Delivery Systems; Glaucoma; Humans; Lubricant Eye Drops; Materials Testing; Microscopy, Electron, Scanning; Muramidase; Nanoparticles; Wetting Agents; Wound Healing | 2021 |
1 trial(s) available for chitosan and Glaucoma
| Article | Year |
|---|---|
Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study.
Topics: Animals; Chitosan; Cornea; Double-Blind Method; Drug Carriers; Drug Stability; Female; Glaucoma; Hydrogen-Ion Concentration; Lipids; Male; Methazolamide; Molecular Weight; Nanoparticles; Particle Size; Rabbits | 2014 |
34 other study(ies) available for chitosan and Glaucoma
| Article | Year |
|---|---|
Chitosan-coated bovine serum albumin nanoparticles for topical tetrandrine delivery in glaucoma:
Topics: Animals; Benzylisoquinolines; Chitosan; Drug Carriers; Glaucoma; Nanoparticles; Particle Size; Rabbits; Serum Albumin, Bovine | 2022 |
3D-printed long-acting 5-fluorouracil implant to prevent conjunctival fibrosis in glaucoma.
Topics: Chitosan; Delayed-Action Preparations; Fluorouracil; Glaucoma; Humans; Printing, Three-Dimensional | 2023 |
Synthesis and evaluation of modified lens using plasma treatment containing timolol-maleate loaded lauric acid-decorated chitosan-alginate nanoparticles for glaucoma.
Topics: Chitosan; Drug Delivery Systems; Glaucoma; Humans; Maleates; Nanoparticles; Ophthalmic Solutions; Timolol | 2023 |
Development of mucoadhesive Timolol loaded chitosan-nanocomposite to treat glaucoma.
Topics: Chitosan; Drug Delivery Systems; Glaucoma; Humans; Mucins; Muramidase; Nanocomposites; Nanoparticles; Timolol | 2023 |
Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation.
Topics: Animals; Cellulose; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Eye; Glaucoma; Intraocular Pressure; Male; Ophthalmic Solutions; Polymers; Rats; Rats, Wistar; Sulfonamides; Thiophenes; Tissue Distribution | 2019 |
Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study.
Topics: Animals; Biological Availability; Carbonic Anhydrase Inhibitors; Chitosan; Cornea; Drug Carriers; Drug Delivery Systems; Glaucoma; Intraocular Pressure; Nanocapsules; Nanoparticles; Ophthalmic Solutions; Particle Size; Pectins; Polyelectrolytes; Rabbits; Sulfonamides; Thiazines | 2020 |
Benzoic acid derivative-modified chitosan-g-poly(N-isopropylacrylamide): Methoxylation effects and pharmacological treatments of Glaucoma-related neurodegeneration.
Topics: Acrylic Resins; Benzoic Acid; Chitosan; Glaucoma; Humans; Neurodegenerative Diseases | 2020 |
The role of aromatic ring number in phenolic compound-conjugated chitosan injectables for sustained therapeutic antiglaucoma efficacy.
Topics: Animals; Chitosan; Drug Delivery Systems; Gelatin; Glaucoma; Humans; Hypertension; Inflammation; Kaempferols; Oxidative Stress; Phenols; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship | 2020 |
Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: A push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy.
Topics: Chitosan; Drug Delivery Systems; Glaucoma; Humans; Nanoparticles; Ophthalmic Solutions | 2020 |
Carboxymethylated chitosan alleviated oxidative stress injury in retinal ganglion cells via IncRNA-THOR/IGF2BP1 axis.
Topics: Antioxidants; Apoptosis; Axons; Cell Line; Cell Proliferation; Cell Survival; Chitosan; Cycloheximide; Glaucoma; Humans; Hydrogen Peroxide; Oxidative Stress; Retinal Ganglion Cells; RNA-Binding Proteins; RNA, Long Noncoding; Signal Transduction | 2021 |
Novel glaucoma model in rats using photo-crosslinked azidobenzoic acid-modified chitosan.
Topics: Animals; Chitosan; Disease Models, Animal; Glaucoma; Intraocular Pressure; Rats; Retinal Ganglion Cells | 2021 |
Preparation of 5-fluorouracil loaded chitosan microtube via in situ precipitation for glaucoma drainage device application: in vitro and in vivo investigation.
Topics: Chitosan; Fluorouracil; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure | 2021 |
Evaluation of a photocrosslinkable hydroxyethyl chitosan hydrogel as a potential drug release system for glaucoma surgery.
Topics: Animals; Anticoagulants; Biocompatible Materials; Chitosan; Drug Delivery Systems; Drug Liberation; Filtering Surgery; Glaucoma; Heparin; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogels; Intraocular Pressure; Male; Materials Testing; Rabbits; Rats | 2017 |
Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma.
Topics: Administration, Topical; Animals; Aqueous Humor; Bentonite; Betaxolol; Cell Survival; Chitosan; Cornea; Delayed-Action Preparations; Dialysis; Drug Carriers; Drug Delivery Systems; Drug Liberation; Epithelial Cells; Glaucoma; Humans; Intraocular Pressure; Nanoparticles; Ophthalmic Solutions; Particle Size; Rabbits; Static Electricity | 2018 |
Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Apoptosis; Blotting, Western; Cells, Cultured; Chitosan; Curcumin; Drug Combinations; Drug Delivery Systems; Epithelium, Corneal; Gelatin; Glaucoma; Humans; Hydrogels; Hydrogen Peroxide; In Situ Nick-End Labeling; Latanoprost; Mitochondria; Nanoparticles; Oxidative Stress; Particle Size; Rabbits; Reactive Oxygen Species; Temperature; Trabecular Meshwork | 2019 |
Engineering and Development of Chitosan-Based Nanocoatings for Ocular Contact Lenses.
Topics: Administration, Ophthalmic; Animals; Antihypertensive Agents; Cattle; Chemical Engineering; Chemistry, Pharmaceutical; Chitosan; Contact Lenses; Cornea; Drug Compounding; Glaucoma; Humans; Nanoparticles; Particle Size; Timolol | 2019 |
Effect of Ultra-Small Chitosan Nanoparticles Doped with Brimonidine on the Ultra-Structure of the Trabecular Meshwork of Glaucoma Patients.
Topics: Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Chitosan; Drug Carriers; Glaucoma; Humans; Models, Theoretical; Nanocomposites; Trabecular Meshwork; Treatment Outcome | 2019 |
Betaxolol hydrochloride loaded chitosan nanoparticles for ocular delivery and their anti-glaucoma efficacy.
Topics: Administration, Ophthalmic; Animals; Antihypertensive Agents; Betaxolol; Chickens; Chitosan; Chorioallantoic Membrane; Drug Carriers; Drug Stability; Glaucoma; Intraocular Pressure; Male; Nanoparticles; Rabbits; Tears; Treatment Outcome | 2013 |
Development of latanoprost-loaded biodegradable nanosheet as a new drug delivery system for glaucoma.
Topics: Absorbable Implants; Alginates; Animals; Antihypertensive Agents; Aqueous Humor; Behavior, Animal; Chitosan; Cornea; Drug Delivery Systems; Glaucoma; Glucuronic Acid; Hexuronic Acids; Intraocular Pressure; Latanoprost; Nanostructures; Prostaglandins F, Synthetic; Rabbits; Rats; Rats, Sprague-Dawley | 2013 |
In situ gelling dorzolamide loaded chitosan nanoparticles for the treatment of glaucoma.
Topics: Animals; Calorimetry, Differential Scanning; Carbonic Anhydrase Inhibitors; Chitosan; Glaucoma; Goats; Humans; In Vitro Techniques; Nanoparticles; Radionuclide Imaging; Sulfonamides; Thiophenes; X-Ray Diffraction | 2014 |
Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits.
Topics: Adhesiveness; Animals; Carteolol; Chitosan; Cornea; Drug Carriers; Glaucoma; Hydroquinones; Intraocular Pressure; Mucous Membrane; Nanoparticles; Particle Size; Permeability; Rabbits; Radionuclide Imaging | 2014 |
A temperature-induced and shear-reversible assembly of latanoprost-loaded amphiphilic chitosan colloids: characterization and in vivo glaucoma treatment.
Topics: Aged; Animals; Chitosan; Colloids; Gels; Glaucoma; Humans; Latanoprost; Male; Prostaglandins F, Synthetic; Rabbits; Rheology; Temperature | 2014 |
CSM enhances the filtration bleb survival in rabbit model of experimental glaucoma surgery.
Topics: Alkylating Agents; Animals; Chitosan; Conjunctiva; Disease Models, Animal; Drug Carriers; Fibrosis; Glaucoma; Injections, Intraocular; Intraocular Pressure; Mitomycin; Postoperative Complications; Rabbits; Trabeculectomy; Wound Healing | 2014 |
Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats.
Topics: Administration, Ophthalmic; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Calorimetry, Differential Scanning; Chitosan; Delayed-Action Preparations; Diminazene; Drug Evaluation, Preclinical; Enzyme Activation; Eye Proteins; Glaucoma; Hyaluronic Acid; Intraocular Pressure; Male; Microscopy, Electron, Scanning; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Tissue Distribution | 2015 |
Evaluation of Chitosan/Aptamer Targeting TGF-β Receptor II Thermo-Sensitive Gel for Scarring in Rat Glaucoma Filtration Surgery.
Topics: Administration, Topical; Animals; Aptamers, Nucleotide; Biocompatible Materials; Blotting, Western; Chitosan; Cicatrix; Conjunctiva; Disease Models, Animal; DNA; Down-Regulation; Filtering Surgery; Gels; Glaucoma; In Situ Nick-End Labeling; Male; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Wound Healing | 2015 |
Preparation and Evaluation of Chitosan Submicroparticles Containing Pilocarpine for Glaucoma Therapy.
Topics: Animals; Chitosan; Chromatography, High Pressure Liquid; Drug Carriers; Glaucoma; Humans; Hydrogen-Ion Concentration; Particle Size; Pilocarpine; Surface Properties; Swine | 2015 |
Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment.
Topics: Administration, Topical; Animals; Aqueous Humor; Chitosan; Cornea; Drug Carriers; Drug Liberation; Glaucoma; Hydrogels; Intraocular Pressure; Latanoprost; Materials Testing; Prostaglandins F, Synthetic; Rabbits; Temperature | 2016 |
Extended wear therapeutic contact lens fabricated from timolol imprinted carboxymethyl chitosan-g-hydroxy ethyl methacrylate-g-poly acrylamide as a onetime medication for glaucoma.
Topics: Animals; Anti-Infective Agents; Cell Line; Cell Survival; Chitosan; Contact Lenses; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Elastic Modulus; Escherichia coli; Glaucoma; Humans; Kinetics; Methacrylates; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Tears; Timolol | 2016 |
Chitosan-g-poly(N-isopropylacrylamide) copolymers as delivery carriers for intracameral pilocarpine administration.
Topics: Acrylic Resins; Administration, Ophthalmic; Animals; Cell Line; Chitosan; Drug Carriers; Glaucoma; Humans; Muscarinic Agonists; Pilocarpine; Rabbits; Spectroscopy, Fourier Transform Infrared | 2017 |
Nimodipine Ophthalmic Formulations for Management of Glaucoma.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Ophthalmic; Animals; beta-Cyclodextrins; Chemistry, Pharmaceutical; Chitosan; Drug Liberation; Freeze Drying; Glaucoma; Hypromellose Derivatives; Intraocular Pressure; Mice, Inbred C57BL; Nimodipine; Ophthalmic Solutions | 2017 |
Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
Topics: Adrenergic beta-Antagonists; Animals; Biological Availability; Carbonic Anhydrase Inhibitors; Chitosan; Drug Carriers; Glaucoma; Hyaluronic Acid; Nanoparticles; Rabbits; Sulfonamides; Thiophenes; Timolol | 2010 |
Ophthalmic drug-loaded N,O-carboxymethyl chitosan hydrogels: synthesis, in vitro and in vivo evaluation.
Topics: Administration, Topical; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Chitosan; Cicatrix; Conjunctiva; Cross-Linking Reagents; Delayed-Action Preparations; Drug Carriers; Female; Filtering Surgery; Fluorouracil; Glaucoma; Hydrogels; In Vitro Techniques; Intraocular Pressure; Iridoid Glycosides; Iridoids; Male; Microscopy, Electron, Scanning; Rabbits; Spectroscopy, Fourier Transform Infrared; Wound Healing | 2010 |
Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.
Topics: Absorbable Implants; Acrylic Resins; Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Alginates; Animals; Brimonidine Tartrate; Calorimetry, Differential Scanning; Cellulose; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Drug Compounding; Glaucoma; Glucuronic Acid; Hexuronic Acids; Hydrophobic and Hydrophilic Interactions; Hypromellose Derivatives; Intraocular Pressure; Kinetics; Methylcellulose; Ophthalmic Solutions; Polymers; Polymethacrylic Acids; Polyvinyls; Povidone; Quinoxalines; Rabbits; Solubility; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; X-Ray Diffraction | 2011 |
Immobilization of drugs for glaucoma treatment.
Topics: Animals; Biocompatible Materials; Cell Survival; Cells, Cultured; Chitosan; Chlorocebus aethiops; COS Cells; Cross-Linking Reagents; Drug Carriers; Drug Delivery Systems; Gelatin; Glaucoma; Humans; Iridoid Glycosides; Iridoids; Materials Testing; Models, Biological; Wettability | 2007 |